Maison Luxe
MASN · OTC
About MASN
- Employees
- 0
- Headquarters
- Des Moines, Iowa
- Listed
- Sep 16, 2010
- Sector
- N/A
- Industry
- N/A
- Website
- clikia.com
MASN key statistics
- Market cap
- 96.02K
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 59.48M
- Volume
- 180.02M
- Open price
- $0.0002
- High today
- $0.0002
- Low today
- $0.0001
- 52 Week high
- $0.0013
- 52 Week low
- $0.0002
Maison Luxe (MASN) at a glance
Maison Luxe (MASN) last traded at $0.0002, with a market cap of 96.02K and a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.0001 and $0.0002. The current price is 100.0% above the day's low and 0.0% below its high.
Volume so far is 180.02M shares, above the average of 59.48M shares a day.
Over the past year Maison Luxe has ranged from $0.0002 to $0.0013, and now sits 0% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- RDARRaadr$0.0002+20.00%
- RCTRedCloud Holdings$0.0827+8.67%
- NUNu Holdings$12.59−16.95%
- EWZiShares MSCI Brazil ETF$34.15−19.82%
- MDEXMadison Technologies$0.0002−33.33%
- BBDBanco Bradesco S.A.$2.93−28.01%
- LTNCLabor Smart$0.0001+0.00%
- TGLTreasure Global$0.2427+9.57%
- AZTRAzitra$1.53
- ITUBItau Unibanco Holding S.A.$7.70−20.37%
Newly listed
Companies that went public in the past six weeks
- LYCALycia Therapeutics$28.85−3.83%
- DAVIDAVION HEALTHCARE$4.07−32.17%
- TCXBTCGX Acquisition Corp. II$10.27−2.10%
- CTYCITY THERAPEUTICS$20.79+0.10%
- IAMIambic Therapeutics$14.41+1.05%
- AMROAmaero$5.37−8.05%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.19%
- TRXBTRex Bio$13.87+0.43%
- RTSNRetension Pharmaceuticals$14.24−6.62%
- PAXGUPine Tree Acquisition$10.02+0.15%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13+0.10%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.